ReviewNeuro-oncology advances

Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005-2022.

Christoph Oster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.